Puma Biotechnology ((PBYI)) has held its Q3 earnings call. Read on for the main highlights of the call. Puma Biotechnology’s recent earnings call presented a balanced sentiment, highlighting both ...
Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...
On this episode of "The Top Line," Fierce Biotech's James Waldron and Fierce Pharma's Fraiser Kansteiner discuss the clinical trial failures that stood out in 2025 and what they suggest about the ...
PitchBook’s 2025 biopharma VC analysis clocked $33.8 billion in capital dispatched in 2025, mainly to companies with ...
The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...
Gary Marshall is the SEO editor at STAT. Trump’s health secretary, Robert F. Kennedy Jr., was the subject of a revelatory profile here. His agenda was so sweeping, we created a tracker to document the ...
Greetings. Welcome to the PDS Biotech's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. At this time, I'll turn the conference ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston CEOs point to a rise in ...
A run of pharmaceutical mergers and acquisitions is fueling optimism that biotechnology venture capital is poised to rebound from its postpandemic slump. With $223 billion in biotech M&A deals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results